Table 3: Prognostic influence of glycemic disturbances on admission with progressive adjustments for potencial confounding factors.
|
Model
1 |
Model
2 |
Model
3 |
ALL |
|
|
|
Hyperglycemia |
1.51 (1.08-2.13) |
1.74 (1.14-2.67) |
1.78 (1.15-2.75) |
Hypoglycemia |
3.37 (1.11-10.24) |
2.6 (0.76-8.89) |
1.88 (0.53-6.73) |
Dysglycemia |
1.62 (1.17-2.26) |
1.83 (1.22-2.75) |
1.81 (1.19-2.75) |
NO DM |
|
|
|
Hyperglycemia |
2.96 (1.6-5.5) |
3.07 (1.47-6.43) |
2.85 (1.36-5.97) |
Hypoglycemia |
9.27 (1.18-72.8) |
3.57 (0.39-32.7) |
2.94 (0.28-30.5) |
Dysglycemia |
3.38 (1.88-6.1) |
3.1 (1.53-6.28) |
2.83 (1.4-5.75) |
Previous
DM |
|
|
|
Hyperglycemia |
1.1 (0.68-1.77) |
1.1 (0.62-1.93) |
1.18 (0.65-2.1) |
Hypoglycemia |
1.23 (0.28-5.45) |
1.64 (0.34-7.96) |
1.23 (0.24-6.41) |
Dysglycemia |
1.1 (0.69-1.76) |
1.14 (0.66-1.97) |
1.2 (0.68-2.1) |
Model 1: dysglycemia + REMS.
Model 2: model 1 + previous
DM, sex, sodium, potassium,
glomerular filtrate, hemoglobin,
thrombocytopenia y leucocytosis.
Model 3: model 2 + Charlson
score.